OSE Immunotherapeutics
Biotech, drug development, immuno-oncology, immuno-inflammation
Your company? Suggest a correction- B2B
- Pharma & life sciences
- Multi-site
- Has in-house R&D
- Handles regulated data
About OSE Immunotherapeutics
Develops first-in-class assets in immuno-oncology and immuno-inflammation, including therapeutic cancer vaccines, monoclonal antibodies for solid tumors, ulcerative colitis, and chronic inflammation, and transplant.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Nantes, Brittany, France
- Founded
- 2012
- Revenue
- €2.7MFY2025, publicly reported
- SIREN
- 479457715
- Website
- ose-immuno.com
Who should you contact at OSE Immunotherapeutics?
Connect to Tamtam to see the decision-makers at OSE Immunotherapeutics, with verified emails and phone numbers, and find more companies like it.
See who to contact, freeOSE Immunotherapeutics at a glance
OSE Immunotherapeutics is a B2B company in the Biotechnology Research industry, headquartered in Nantes, Brittany, France.
OSE Immunotherapeutics was founded in 2012.
OSE Immunotherapeutics has 51–250 employees.
OSE Immunotherapeutics's revenue is €2.7M (FY2025, publicly reported).
OSE Immunotherapeutics's SIREN number is 479457715.
Frequently asked questions about OSE Immunotherapeutics
What is OSE Immunotherapeutics's revenue?
OSE Immunotherapeutics's revenue is €2.7M (FY2025, publicly reported).
How many employees does OSE Immunotherapeutics have?
OSE Immunotherapeutics has 51–250 employees.
Where is OSE Immunotherapeutics headquartered?
OSE Immunotherapeutics is headquartered in Nantes, Brittany, France.
Selling to companies like OSE Immunotherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies